Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
PhageLine unpacks the science of bacteriophages, one paper at a time. From groundbreaking studies to surprising discoveries, we translate complex research into engaging conversations. Whether you are steeped in microbiology or just discovering the fascinating world of phages, PhageLine delivers a unique perspective on the science behind these bacterial predators.
PhageLine is on BlueSky. Follow us never to miss anything again.
This podcast is generated using artificial intelligence. Infectious disease scientists review the scripts before production.
| Episode | Date |
|---|---|
|
PhageLine #32: Antibiotic and Probiotic Effects on the Gut Phageome
|
Oct 11, 2025 |
|
PhageLine #31: Bacteriophage-Mediated Vitamin B12 Release
|
Oct 04, 2025 |
|
PhageLine #30: Bacteriophage-Fusidic Acid Synergy In An Ex Vivo Dermis Model
|
Sep 20, 2025 |
|
PhageLine #29: Phage Therapy With Artificial Antigen-Directed Immune Labeling
|
Sep 13, 2025 |
|
PhageLine #28: A Beginner’s Guide to Viral Diversity
|
Sep 07, 2025 |
|
PhageLine #27: Anti-Restriction Phage Proteins
|
Aug 30, 2025 |
|
PhageLine #26: Selection and Cost of Bacteriophage Resistance
|
Aug 23, 2025 |
|
PhageLine #25: Efficacy of Sequential Phage-Colistin Therapy
|
Aug 16, 2025 |
|
PhageLine #24: A Phage Hydrogel for Burn Wounds
|
Aug 09, 2025 |
|
PhageLine #23: Bacteriophage Vaccine Against PEDV
|
Jul 05, 2025 |
|
PhageLine #22: Phage-Antibiotic Synergy
|
Jun 28, 2025 |
|
PhageLine #21: Microplastics and Bacteriophages
|
Jun 21, 2025 |
|
PhageLine #20: Is SARS-CoV-2 a Bacteriophage?
|
Jun 14, 2025 |
|
PhageLine #19: Targeted Discovery by Co-Culture (Phage DisCo)
|
May 31, 2025 |
|
PhageLine #18: A Highly Robust Acinetobacter baumannii Phage
|
May 24, 2025 |
|
PhageLine #17: Personalized Phage Therapy in Cystic Fibrosis Infections
|
May 17, 2025 |
|
PhageLine #16: Bacteriophage Interactions
|
May 10, 2025 |
|
PhageLine #15: Identifying Phage Depolymerases
|
May 03, 2025 |
|
PhageLine #14: Phage Recognition and Immunogenicity in Humans
|
Apr 26, 2025 |
|
PhageLine #13: Optimizing Bacteriophage Engineering Through an Accelerated Evolution Platform
|
Apr 12, 2025 |
|
PhageLine #12: Biofilm Models for Phage Therapy of Diabetic Foot Ulcers
|
Apr 05, 2025 |
|
PhageLine #11: Adsorption Mechanisms
|
Mar 29, 2025 |
|
PhageLine #10: Phage-Derived Endolysins in Food Safety
|
Mar 22, 2025 |
|
PhageLine #9: Functional Genomics with CRISPRi-ART
|
Mar 15, 2025 |
|
PhageLine #8: Synergy of Mucoactive Drugs and Phages
|
Mar 08, 2025 |
|
PhageLine #7: The BREX Anti-Phage Immunity System
|
Mar 01, 2025 |
|
PhageLine #6: Phages and Nitric Oxide on Medical Devices
|
Feb 22, 2025 |
|
PhageLine #5: The LNT103 engineered endolysin for Gram-negative pathogens
|
Feb 15, 2025 |
|
PhageLine #4: 100 Cases of Personalized Phage Therapy
|
Feb 08, 2025 |
|
PhageLine #3: Bacteriophage-Based Biosensors
|
Feb 01, 2025 |
|
PhageLine #2: Phage Isolation and Characterization
|
Jan 25, 2025 |
|
PhageLine #1: An Overview of Phage Therapy
|
Jan 18, 2025 |